AIBCCR 2021: Going Beyond BCG to Exploit Immunomodulation for Bladder Cancer
AIBCCR 2021 alternative treatment approaches to BCG, cost of bladder cancer care, results of the global BCG shortage, enfortumab vedotin (EV), sacituzumab govitecan (SG), cGAS-STING pathway.